Citius Pharmaceuticals
CTXR
CTXR
31 hedge funds and large institutions have $1.48M invested in Citius Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.33% more ownership
Funds ownership: 7.4% → 8.73% (+1.3%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
31
Holding in Top 10
–
Calls
$78K
Puts
$70K
Top Buyers
| 1 | +$292K | |
| 2 | +$254K | |
| 3 | +$200K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$39.8K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$32K |
Top Sellers
| 1 | -$282K | |
| 2 | -$90.9K | |
| 3 | -$21K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.57K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$4.28K |
